高流量鼻导管撤除:谁、何时、如何?
高流量鼻导管(HFNC)是急性呼吸衰竭的一线治疗,但缺乏高质量证据指导其撤除。本文提出以生理学为导向的标准化撤除(liberation)流程,采用阶梯式方法,旨在提高护理效率和资源利用。
要点
- HFNC撤除决策常缺乏明确指导,过早或过晚撤除均可能带来不良后果。
- 延迟降阶梯可能导致ICU/住院时间延长、费用增加和资源紧张。
- 建议采用类似机械通气自主呼吸试验的阶梯式撤除流程。
核心结论
- 提出以生理学为导向的标准化HFNC撤除(liberation)流程,采用阶梯式方法。
主要发现
- HFNC使用增加但撤除缺乏高质量证据。
- 流量、FiO2或两者同时降低的速度常由临床医生自行决定,无明确最优方案。
- 未能适时降阶梯可能导致ICU/住院时间延长、医疗费用增加和有限资源可用性降低。
临床怎么用
- 可参考类似机械通气自主呼吸试验的阶梯式撤除流程,以生理学指标指导HFNC降阶梯。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-flow nasal cannula (HFNC) is a first-line therapy for patients with acute respiratory failure. Despite increased HFNC utilization over recent years-accelerated in part by the COVID-19 pandemic-high-quality evidence to guide HFNC discontinuation is lacking. Decisions about when and how quickly to reduce flow rate, Fio2, or both simultaneously are frequently left to clinicians' discretion without clear guidance on an optimal approach. Failure to de-escalate HFNC support when clinically appropriate has many potential consequences, such as prolongation of ICU/hospital length of stay, increased health care costs, and reduced availability of limited hospital resources. With the goal of improving care efficiency and resource utilization among hospitalized patients with acute respiratory failure, we propose a standardized approach for HFNC discontinuation focused on "liberation" (similar to spontaneous breathing trials for patients undergoing mechanical ventilation), using a stepwise approach guided by physiology.
引用
- Freeman H, Vranas KC, Tuthill S, et al. High-Flow Nasal Cannula Liberation: Who, When, and How? Chest. 2025. PMID: 39929280. doi:10.1016/j.chest.2025.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。